Cargando…

Severe Asthma, Telemedicine, and Self-Administered Therapy: Listening First to the Patient

Severe asthma patients are at an increased risk of major complications and they need to be monitored regularly. The COVID-19 pandemic has notably impacted on the health care resources. The telemedicine approach applied to the follow-up of asthmatic patients has been proven to be effective in monitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Guarnieri, Gabriella, Caminati, Marco, Achille, Alessia, Vaia, Rachele, Chieco Bianchi, Fulvia, Senna, Gianenrico, Vianello, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880352/
https://www.ncbi.nlm.nih.gov/pubmed/35207233
http://dx.doi.org/10.3390/jcm11040960
_version_ 1784659173855723520
author Guarnieri, Gabriella
Caminati, Marco
Achille, Alessia
Vaia, Rachele
Chieco Bianchi, Fulvia
Senna, Gianenrico
Vianello, Andrea
author_facet Guarnieri, Gabriella
Caminati, Marco
Achille, Alessia
Vaia, Rachele
Chieco Bianchi, Fulvia
Senna, Gianenrico
Vianello, Andrea
author_sort Guarnieri, Gabriella
collection PubMed
description Severe asthma patients are at an increased risk of major complications and they need to be monitored regularly. The COVID-19 pandemic has notably impacted on the health care resources. The telemedicine approach applied to the follow-up of asthmatic patients has been proven to be effective in monitoring their disease and their adherence to the therapy. The aim of our study was to investigate the satisfaction of severe asthma patients before the activation of a telemedicine management, as well as their current experience with self-administration of injection therapy. An ad hoc questionnaire was developed and sent by e-mail to 180 severe asthma patients. Most of subjects, 82%, were confident with the idea of doing self-measurements and self-managing their disease. Further, 77% of subjects favoured to carry out virtual visits and telemedicine. Regarding the home treatment, 93% of patients considered the self-injection therapy easy, 94% of subjects felt safe, and 93% were not worried while self-administering. Only mild adverse events were reported in 22% of patients after self-administration. Our results showed an agreement between what is considered necessary and practicable by healthcare personnel and what is perceived by the severe asthma patients in terms of treatment and monitoring of the disease with Telehealth. Biologics have a safety profile and can be easily self-administred at home.
format Online
Article
Text
id pubmed-8880352
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88803522022-02-26 Severe Asthma, Telemedicine, and Self-Administered Therapy: Listening First to the Patient Guarnieri, Gabriella Caminati, Marco Achille, Alessia Vaia, Rachele Chieco Bianchi, Fulvia Senna, Gianenrico Vianello, Andrea J Clin Med Brief Report Severe asthma patients are at an increased risk of major complications and they need to be monitored regularly. The COVID-19 pandemic has notably impacted on the health care resources. The telemedicine approach applied to the follow-up of asthmatic patients has been proven to be effective in monitoring their disease and their adherence to the therapy. The aim of our study was to investigate the satisfaction of severe asthma patients before the activation of a telemedicine management, as well as their current experience with self-administration of injection therapy. An ad hoc questionnaire was developed and sent by e-mail to 180 severe asthma patients. Most of subjects, 82%, were confident with the idea of doing self-measurements and self-managing their disease. Further, 77% of subjects favoured to carry out virtual visits and telemedicine. Regarding the home treatment, 93% of patients considered the self-injection therapy easy, 94% of subjects felt safe, and 93% were not worried while self-administering. Only mild adverse events were reported in 22% of patients after self-administration. Our results showed an agreement between what is considered necessary and practicable by healthcare personnel and what is perceived by the severe asthma patients in terms of treatment and monitoring of the disease with Telehealth. Biologics have a safety profile and can be easily self-administred at home. MDPI 2022-02-12 /pmc/articles/PMC8880352/ /pubmed/35207233 http://dx.doi.org/10.3390/jcm11040960 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Brief Report
Guarnieri, Gabriella
Caminati, Marco
Achille, Alessia
Vaia, Rachele
Chieco Bianchi, Fulvia
Senna, Gianenrico
Vianello, Andrea
Severe Asthma, Telemedicine, and Self-Administered Therapy: Listening First to the Patient
title Severe Asthma, Telemedicine, and Self-Administered Therapy: Listening First to the Patient
title_full Severe Asthma, Telemedicine, and Self-Administered Therapy: Listening First to the Patient
title_fullStr Severe Asthma, Telemedicine, and Self-Administered Therapy: Listening First to the Patient
title_full_unstemmed Severe Asthma, Telemedicine, and Self-Administered Therapy: Listening First to the Patient
title_short Severe Asthma, Telemedicine, and Self-Administered Therapy: Listening First to the Patient
title_sort severe asthma, telemedicine, and self-administered therapy: listening first to the patient
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880352/
https://www.ncbi.nlm.nih.gov/pubmed/35207233
http://dx.doi.org/10.3390/jcm11040960
work_keys_str_mv AT guarnierigabriella severeasthmatelemedicineandselfadministeredtherapylisteningfirsttothepatient
AT caminatimarco severeasthmatelemedicineandselfadministeredtherapylisteningfirsttothepatient
AT achillealessia severeasthmatelemedicineandselfadministeredtherapylisteningfirsttothepatient
AT vaiarachele severeasthmatelemedicineandselfadministeredtherapylisteningfirsttothepatient
AT chiecobianchifulvia severeasthmatelemedicineandselfadministeredtherapylisteningfirsttothepatient
AT sennagianenrico severeasthmatelemedicineandselfadministeredtherapylisteningfirsttothepatient
AT vianelloandrea severeasthmatelemedicineandselfadministeredtherapylisteningfirsttothepatient